| Primary |
| Multiple Myeloma |
51.8% |
| Product Used For Unknown Indication |
17.3% |
| Plasma Cell Myeloma |
6.5% |
| Mantle Cell Lymphoma |
4.5% |
| Prophylaxis |
3.5% |
| Drug Use For Unknown Indication |
3.3% |
| Acute Myeloid Leukaemia |
2.3% |
| T-cell Lymphoma |
2.0% |
| Hypertension |
1.2% |
| Pain |
1.1% |
| Amyloidosis |
1.1% |
| Diffuse Large B-cell Lymphoma |
0.8% |
| B Precursor Type Acute Leukaemia |
0.8% |
| Acute Lymphocytic Leukaemia |
0.7% |
| Constipation |
0.6% |
| Non-hodgkin's Lymphoma |
0.6% |
| Non-small Cell Lung Cancer |
0.6% |
| Leukaemia Plasmacytic |
0.6% |
| Peripheral T-cell Lymphoma Unspecified |
0.5% |
| Nausea |
0.5% |
|
| Death |
23.4% |
| Thrombocytopenia |
11.0% |
| White Blood Cell Count Decreased |
7.3% |
| Vomiting |
6.0% |
| Neuropathy Peripheral |
5.3% |
| Pyrexia |
5.2% |
| Pneumonia |
4.5% |
| Disease Progression |
4.1% |
| Sepsis |
3.8% |
| Platelet Count Decreased |
3.5% |
| Weight Decreased |
3.5% |
| Multiple Myeloma |
3.2% |
| Tumour Lysis Syndrome |
3.2% |
| Infection |
2.9% |
| Renal Failure |
2.4% |
| Respiratory Failure |
2.4% |
| Septic Shock |
2.2% |
| Lung Disorder |
2.2% |
| Off Label Use |
2.0% |
| Urinary Tract Infection |
1.9% |
|
| Secondary |
| Multiple Myeloma |
37.4% |
| Product Used For Unknown Indication |
14.6% |
| Plasma Cell Myeloma |
9.1% |
| Prophylaxis |
8.8% |
| Drug Use For Unknown Indication |
6.9% |
| Mantle Cell Lymphoma |
4.2% |
| Hypertension |
2.0% |
| Constipation |
1.9% |
| Pain |
1.8% |
| Nausea |
1.7% |
| Acute Myeloid Leukaemia |
1.5% |
| Non-hodgkin's Lymphoma |
1.5% |
| Diffuse Large B-cell Lymphoma |
1.4% |
| B-cell Lymphoma |
1.2% |
| Lymphoma |
1.1% |
| Diarrhoea |
1.0% |
| Cardiac Failure |
1.0% |
| Amyloidosis |
0.9% |
| Waldenstrom's Macroglobulinaemia |
0.9% |
| Insomnia |
0.8% |
|
| Thrombocytopenia |
12.8% |
| Vomiting |
10.3% |
| Pneumonia |
9.0% |
| Neuropathy Peripheral |
8.0% |
| Pyrexia |
6.7% |
| White Blood Cell Count Decreased |
5.3% |
| Renal Failure Acute |
5.2% |
| Sepsis |
4.9% |
| Urinary Tract Infection |
4.8% |
| Platelet Count Decreased |
3.6% |
| Haemoglobin Decreased |
3.4% |
| Tumour Lysis Syndrome |
3.2% |
| Weight Decreased |
3.2% |
| Diarrhoea |
3.1% |
| Septic Shock |
2.9% |
| Multiple Myeloma |
2.9% |
| Death |
2.8% |
| Renal Failure |
2.8% |
| Acute Myeloid Leukaemia |
2.6% |
| Pancytopenia |
2.5% |
|
| Concomitant |
| Multiple Myeloma |
31.7% |
| Product Used For Unknown Indication |
25.2% |
| Drug Use For Unknown Indication |
15.5% |
| Plasma Cell Myeloma |
8.0% |
| Prophylaxis |
5.5% |
| Pain |
3.6% |
| Chemotherapy |
1.3% |
| Hypertension |
1.3% |
| Nausea |
1.2% |
| Refractory Cancer |
0.9% |
| Depression |
0.9% |
| Anxiety |
0.8% |
| Metastases To Bone |
0.7% |
| Osteoporosis |
0.5% |
| Adverse Event |
0.5% |
| Hypercalcaemia |
0.5% |
| Anaemia |
0.5% |
| Constipation |
0.5% |
| Nuclear Magnetic Resonance Imaging |
0.4% |
| Neuropathy Peripheral |
0.4% |
|
| Multiple Myeloma |
9.1% |
| Weight Decreased |
7.5% |
| Vomiting |
7.0% |
| Pneumonia |
6.6% |
| Death |
6.5% |
| Thrombocytopenia |
5.9% |
| Tooth Extraction |
5.9% |
| Plasma Cell Myeloma |
5.1% |
| Renal Failure Acute |
4.8% |
| Rash |
4.3% |
| Renal Failure |
4.2% |
| Sepsis |
4.2% |
| Neuropathy Peripheral |
4.1% |
| Urinary Tract Infection |
4.0% |
| Wound Drainage |
3.7% |
| Platelet Count Decreased |
3.6% |
| Pancytopenia |
3.5% |
| Osteonecrosis |
3.4% |
| Weight Increased |
3.4% |
| White Blood Cell Count Decreased |
3.2% |
|
| Interacting |
| Multiple Myeloma |
33.9% |
| Product Used For Unknown Indication |
33.0% |
| Plasma Cell Myeloma |
7.3% |
| Nausea |
5.5% |
| Vomiting |
5.5% |
| Infection Prophylaxis |
2.8% |
| Candidiasis |
1.8% |
| Oropharyngeal Pain |
1.8% |
| Plasmacytoma |
1.8% |
| Tongue Ulceration |
1.8% |
| Cancer Pain |
0.9% |
| Hyperuricaemia |
0.9% |
| Laryngitis |
0.9% |
| Pain |
0.9% |
| Prophylaxis |
0.9% |
|
| Leukoencephalopathy |
42.1% |
| Pyrexia |
15.8% |
| Sinus Bradycardia |
10.5% |
| Febrile Neutropenia |
5.3% |
| Osteonecrosis |
5.3% |
| Platelet Count Decreased |
5.3% |
| Skin Exfoliation |
5.3% |
| White Blood Cell Count Decreased |
5.3% |
| Wrong Technique In Drug Usage Process |
5.3% |
|
